Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders Volume 1, 2000 - Issue 3
Journal homepage
31
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse

Ken Ikeda Fourth Department of Internal Medicine Toho University Ohashi Hospital Tokyo, Japan
,
Yasuo Iwasaki Fourth Department of Internal Medicine Toho University Ohashi Hospital Tokyo, Japan
&
Masao Kinoshita Fourth Department of Internal Medicine Toho University Ohashi Hospital Tokyo, Japan
Pages 207-212 | Published online: 10 Jul 2009

  • O'Gorman E, Beutner C, Wallimann T, Brdiczka D. Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain. Biochem Biophys Acta 1996; 1276: 161-170.
  • Matthews RT, Yang L, Jenkins BC, et al. Neuroprotective effects of creatine and cyclocreatine in animal models in Huntington's disease. J Neurosci 1998; 18: 156-163.
  • Klivenyi P, Ferrante RJ, Matthews RT, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Med 1999; 5: 347-350.
  • Tarnopolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 1999; 52: 854-857.
  • Ikeda K, Klinkosz B, Creene T, et al. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol 1995; 37: 505-511.
  • Ikeda K, Kinoshita M, Iwasaki Y, Tagaya N, Shiojima T. Ledthinized Superoxide dismutase retards wobbler mouse motoneuron disease. Neuromusc Disord 1995; 5: 383-390.
  • Ikeda K, Iwasaki Y, Tagaya N, Shiojima T, Kobayashi T, Kinoshita M. Neuroprotective effect of basic fibroblast growth factor on wobbler mouse motor neuron disease. Neurol Res 1995; 17: 445-448.
  • Ikeda K, Iwasaki Y, Tagaya N, Shiojima T, Kinoshita M. Neuroprotective effect of cholinergic differentiation factor/leukemia inhibitory factor (CDF/IIF) on wobbler murine motor neuron disease. Muscle Nerve 1995; 18: 1344-1347.
  • Ikeda K, Kinoshita M, Tagaya N, et al. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease. Brain Res 1996; 726: 91-97.
  • Ikeda K, Iwasaki Y, Kinoshita M. JTP-2942, a novel thyrotropin-releasing hormone analogue, protects against spinal motor neuron degeneration in the wobbler mouse. Neurosci Lett 1998; 250: 9-12.
  • Ikeda K, Iwasaki Y, Kinoshita M. Neuronal nitric oxide synthase inhibitor, 7-nitroindazole, delays motor dysfunction and spinal motoneuron degeneration in the wobbler mouse. J Neurol Sci 1998; 160: 9-15.
  • Mitsumoto H, Ikeda K, Holmlund TH, et al. The effect of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol 1994; 36: 142-148.
  • Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Iindsay RM. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 1994; 265: 1107-1110.
  • Ikeda K, Wong V, Holmlund TH, et al. Histometric effects of ciliary neurotrophic factor in wobbler mouse motor neuron disease. Ann Neurol 1995; 37: 47-54.
  • Duchen LW, Strich SJ. An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant 'wobbler'. J Neurol Neurosurg Psychiatry 1968; 31: 535-542.
  • Mitsumoto H, Bradley WC. The wobbler mouse: the murine motor neuron disease: degeneration and regeneration of the lower motor neuron. Brain 1982; 105: 811-834.
  • Wallimann T, Wyss M, Brdkzka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992; 281: 21-40.
  • Cuimbal C, Kilimann MW. A Na+-dependent creatine transporter in rabbit brain, muscle, heart and kidney. J Biol Chem 1993; 268: 8418-8421.
  • Hemmer W, Wallimann T. Functional aspects of creatine kinase in brain. Dev Neurosci 1993; 15: 246-260.
  • Tarnopolsky MA, Roy BD, MacDonald JR A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 1997; 20: 1502-1509.
  • Ikeda K, Kinoshita M, Iwasaki Y, Wakata N. Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 2000; 54: 537.
  • Sipilä I, Rapola J, Simell O, Vannas A. Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina. N Engl J Med 1981; 304: 867-870.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.